Hassona MD, Abouelnaga ZA, Elnakish MT, Awad MM, Alhaj M, Goldschmidt-Clermont PJ, Hassanain H. Vascular hypertrophy-associated hypertension of profilin1 transgenic mouse model leads to functional remodeling of peripheral arteries. Am J Physiol Heart Circ Physiol 298: H2112-H2120, 2010. First published April 16, 2010; doi:10.1152/ajpheart.00016.2010.-Increased mechanical stress/ hypertension in the vessel wall triggers the hypertrophic signaling pathway, resulting in structural remodeling of vasculature. Vascular hypertrophy of resistance vessels leads to reduced compliance and elevation of blood pressure. We showed before that increased expression of profilin1 protein in the medial layer of the aorta induces stress fiber formation, triggering the hypertrophic signaling resulting in vascular hypertrophy and, ultimately, hypertension in older mice. Our hypothesis is that profilin1 induced vascular hypertrophy in resistance vessels, which led to elevation of blood pressure, both of which contributed to the modulation of vascular function. Our results showed significant increases in the expression of ␣1-and ␤1-integrins (280 Ϯ 6.3 and 325 Ϯ 7.4%, respectively) and the activation of the Rho/Rho-associated kinase (ROCK) II pathway (260 and 350%, respectively, P Ͻ 0.05) in profilin1 mesenteric arteries. The activation of Rho/ROCK led to the inhibition of endothelial nitric oxide synthase expression (39 Ϯ 5.4%; P Ͻ 0.05) and phosphorylation (35 Ϯ 4.5%; P Ͻ 0.05) but also an increase in myosin light chain 20 phosphorylation (372%, P Ͻ 0.05). There were also increases in hypertrophic signaling pathways in the mesenteric arteries of profilin1 mice such as phospho-extracellular signal-regulated kinase 1/2 and phospho-c-Jun NH2-terminal kinase (312.15 and 232.5%, respectively, P Ͻ 0.05). Functional analyses of mesenteric arteries toward the vasoactive drugs were assessed using wire-myograph and showed significant increases in the vascular responses of profilin1 mesenteric arteries toward phenylephrine, but significant decreases in response toward ROCK inhibitor Y-27632, ACh, sodium nitrite, and cytochalasin D. The changes in vascular responses in the mesenteric arteries of profilin1 mice are due to vascular hypertrophy and the elevation of blood pressure in the profilin1 transgenic mice. functional remodeling; mesenteric arteries; wire-myograph HYPERTENSION REPRESENTS A major risk factor for cardiovascular events such as stroke and myocardial infarction. Resistance vessels play an important role in regulating blood pressure. These vessels include small arteries and arterioles, with diameters ranging from 15 to 300 m (14, 25).
compliance and elevation of blood pressure (34, 53, 20) . Remodeling of the vasculature is an active process of structural changes that involves alterations in cellular processes, including growth and changes in the extracellular matrix integrincytoskeleton axis, resulting in an increase in the media-tolumen ratio (13, 20) . Physiological remodeling is an adaptive process occurring in response to hemodynamic changes and aging. However, when this process becomes maladaptive, it plays a role in hypertension's complications (51, 31) .
Increased mechanical strain/hypertension in the vessel wall triggers the hypertrophic signaling pathway resulting in structural remodeling of vasculature (32) . Therefore, regular and stable mechanical stimulation appears to be required for maintenance of normal contractile phenotype of vascular smooth muscle cells (VSMCs) in the arterial wall (4) . Our previous findings showed that increased actin polymerization and stress fiber formation via overexpression of profilin1 in the blood vessel medial layer of transgenic mice generate mechanical force and led to vascular hypertrophy and hypertension (32) . Profilin1 is a key actin-regulatory protein that enhances the extent of actin polymerization in the presence of other actinregulatory proteins and delivering ATP-G-actin to the growing end of filaments (6) . Profilin, therefore, has an essential role in regulating de novo actin polymerization, particularly actin treadmilling (6, 49) . Elevated expression of profilin1 gene in VSMCs of profilin1 mice favoring F-actin induces stress fiber formation and plays an important role in vascular hypertrophy by inducing internal mechanical stress and triggering the hypertrophic signaling pathway resulting in vascular remodeling. This led to high blood pressure by the time the profilin1 mice were six months old (32) .
Mechanical stretch/hypertension can also affect the small GTP-binding protein in the Rho pathway. Moreover, ANG II leads to activation of Rho, a key regulator of the actin cytoskeleton (45) . Many studies suggest that pathological vascular remodeling is due to augmented Rho or Rho-associated kinase (ROCKI and ROCKII isoforms) activity (35, 39) . Rho and ROCK play an important role in blood pressure regulation, particularly in hypertension (13) . Biochemical analysis showed that the expression of ROCK was augmented in blood vessels of spontaneous hypertensive rats (33) . In addition, the activation of Rho/ROCK pathways downregulates endothelial nitric oxide synthase (eNOS) gene expression and phosphorylation (31) .
Furthermore, the mitogen-activated protein (MAP) kinase cascade is a major pathway through which signals coming from growth factors and mechanical strain are transduced into the regulation of gene expression and protein synthesis. Mechan-ical strain activates both extracellular signal-regulated kinase (ERK) 1/2 and c-Jun NH 2 -terminal kinase (JNK) in VSMCs, leading to vascular hypertrophy (13, 32, 47, 57, 59) . Events downstream to MAP kinase activation are numerous and varied. Once the MAP kinase pathway is activated, it phosphorylates transcription factors such as activator protein-1 (AP1) that thereby regulate cell cycle gene expression (1, 13) . Activation of Rho/ROCK and MAP kinase pathways modulates changes in the vessel wall leading to structural remodeling (33) .
The structural remodeling of small blood vessels would alter the response to vasoactive agents as shown in hypertensive patients (8) . The structural abnormalities of resistance arteries enhance vasoconstrictor responses, contributing to elevated vascular tone (8) .
Our goal in this study was to assess the functional changes toward vasoactive agents as a result of the vascular hypertrophy in resistance vessels and increase in blood pressure using the profilin1 transgenic model. This model was developed in our laboratory by transgenically overexpressing the cDNA of the human profilin1 gene in VSMCs using the mouse vascular smooth muscle ␣-actin promoter. 85-23, revised 1996) . For this study, we used male profilin1 transgenic mice and age-matched nontransgenic controls. The construct and the procedure for the generation and characterization genotyping of the profilin1 transgenic mice have been described previously (32) . Unless otherwise stated, all the experiments were repeated three times and performed with heterozygous transgenic profilin1 mice (8 -12 mo old) with age-matched nontransgenic littermates. Six to eight mice per genotype were used for ACh experiment.
MATERIALS AND METHODS

Animals
The MAP of the profilin1 mice at the time of experiment was 140 Ϯ 3 and the MAP of control littermates 105 Ϯ 5 (SD).
Western blot analysis. Mesenteric arteries isolated from mice were cleaned from fat and homogenized in RIPA buffer (Upstate Biotechnology). Mesenteric lysates from profilin1 and nontransgenic control mice (n ϭ 6) were separated on SDS-polyacrylamide (4 -20%) gels and transferred to nitrocellulose membrane (Hybond ECL; Amersham International). Membranes were blocked in 5% BSA and subsequently incubated in specific antibodies. The following antibodies were used: anti-total ERK1/2, total JNK, total eNOS (Cell Signaling), Rho/ ROCKII, anti-mouse integrin ␣ 1, anti-goat integrin ␤1 (Santa Cruz), anti-human profilin1, phospho-ERK1/2, phospho-JNK, phospho-myosin light chain (MLC) 20, phospho-eNOS (Ser 1177 ) (Cell Signaling), and Rho-GTPase assay kits. The membrane was stripped and probed with ␤-actin antibody as an internal positive control protein for equal protein loading. The bands were visualized with an enhanced chemiluminescence system (Amersham Biosciences). The autoradiograph was quantified with laser densitometry software (GS-800 Densitometer; Bio-Rad, Hercules, CA). The changes in profilin1 mesenteric artery signaling were assessed as a percentage of the nontransgenic control.
Histology. The mesenteric arteries from profilin1 transgenic and nontransgenic littermates were cleaned from fat, divided into small segments, and fixed in 10% neutral buffered formalin. Histological analysis was performed on 4-m sections from formalin-fixed and paraffin-embedded tissue using an ABC kit according to the manufacturer's instructions (Vector Laboratories). Hematoxylin and eosin (H&E) staining procedures were performed according to standard protocols. Hypertrophy was quantified by assessing the media-tolumen ratios in cross sections of mesenteric arteries after H&E staining. We have measured 30 mesenteric artery cross sections from profilin1 or nontransgenic control mice using the MetaMorph software (version 4.6).
Vascular reactivity. Mice were anesthetized with pentobarbital sodium, and the mesentery was rapidly excised and placed in an ice-cold HEPES-physiological saline solution (PSS). The composition of HEPES-PSS was as follows (in mM): 142 NaCl, 4.7 KCl, 1.17 MgSO4, 1.56 Ca2Cl, 1.18 KH2PO4, 10 HEPES, and 5.5 glucose. Second-order branches of mesenteric artery (2 mm in length with internal diameter 150 -200 mm) were carefully dissected and mounted as ring preparations on two stainless steel wires. The second-order mesenteric arteries were mounted in an isometric Mulvany-Halpern small vessel myograph (40 mm diameter; model 610 M; Danish Myo Technology), and data were acquired by a PowerLab 8/SP data acquisition system (AD Instruments, Castle Hill, Australia). A resting tension of 3 mN was imposed on the second-order mesenteric arteries, and vessels were equilibrated for 1 h in HEPES-PSS at 37°C and continuously bubbled with 5% CO2 and 95% O2. Arterial integrity was assessed first by stimulation of vessels with 80 mM KCl. Endothelium integrity was assessed by measuring the dilatory response to ACh (1 M) in phenylephrine-contracted vessels (3 M). The failure of ACh to relax denuded mesenteric rings was considered proof of endothelium disruption. In second-order mesenteric arteries, the dilatory responses were assessed on phenylephrine-contracted vessels (3 M).
Statistical analysis. Data are presented as means Ϯ SE. Statistical significance was analyzed with the Student's t-test. A value of P Ͻ 0.05 was considered significant.
RESULTS
The human profilin1 protein is expressed in mesenteric arteries of profilin1 mice. To confirm the overexpression of the human profilin1 protein in resistant vessels, we performed Western blot analysis on protein extracts from mesenteric arteries of profilin1 mice using human profilin1 antibody. Our results showed a significant increase in human profilin1 protein expression in mesenteric arteries of the transgenic mice compared with the endogenous mouse profilin1 in nontransgenic controls (200 Ϯ 5.5%; P Ͻ 0.05) (Fig. 1A) .
Overexpression of profilin1 results in mesenteric artery hypertrophy. We performed a histological analysis to examine the integrity of the mesenteric arteries in profilin1 transgenic mice compared with matched nontransgenic control littermates. The H&E staining showed clear signs of remodeling and vascular hypertrophy in the mesenteric arteries of profilin1 transgenic mice as assessed by measuring the medial thickness and lumen diameter in cross sections of mesenteric arteries using MetaMorph software (version 4.6). Our results showed a significant increase in media-to-lumen ratios of profilin1 mesenteric arteries (40 Ϯ 2.1%; P Ͻ 0.05) compared with nontransgenic controls (26 Ϯ 1.3%; P Ͻ 0.05) (Fig. 1B) .
The expression of ␣ 1 -and ␤ 1 -integrins is increased in the mesenteric arteries of profilin1 mice. Profilin1-induced stress fiber formation generates mechanical force that may modulate changes in cell adhesion molecules such as integrins. ␣ 1 ␤ 1 -Integrin, which is known to bind collagen, is implicated in arterial stiffness (28) . Therefore, we sought to assess the changes in ␣ 1 ␤ 1 -integrin expression as a result of profilin1-induced mechanical stress on the vessel wall.
Our results showed significant increases in the expression of ␣ 1 -and ␤ 1 -integrin in mesenteric arteries of transgenic mice compared with control mice (280 Ϯ 6.3 and 325 Ϯ 7.4%, respectively, P Ͻ 0.05) (Fig. 2, A and B) .
The hypertrophic signaling pathways are activated in mesenteric arteries of profilin1 mice. The increased ␣ 1 -and ␤ 1 -integrin expression via profilin1-induced stress fibers can lead to the activation of ERK1/2 and JNK, key kinases in the hypertrophic signaling pathway (1, 13, 29, 59 ). Therefore, we assessed the activation of these two important kinases, ERK1/2 and JNK, in the mesenteric arteries in profilin1 mice. Western blot analyses were performed on protein extracts isolated from the mesenteric arteries of profilin1 and nontransgenic controls using antiphospho-ERK1/2 and antiphospho-JNK antibodies. Our results showed that profilin1 mesenteric arteries have significantly higher levels of phosphorylated ERK1/2 (312 Ϯ 7.31%; P Ͻ 0.05) and JNK than the nontransgenic controls (232 Ϯ 6.49%; P Ͻ 0.05). In addition, Western blots performed using anti-ERK and anti-JNK antibodies showed no changes in total ERK1/2 and JNK protein levels among groups (Fig. 3, A and B) .
Rho/ROCK pathway is activated in the mesenteric arteries of profilin1 mice. The Rho protein, through its downstream effector ROCK, mediates cytoskeletal reorganization and smooth muscle cell (SMC) contraction and is implicated in the pathophysiology of hypertension (31, 35) . A specific inhibition of ROCK prevents agonist-induced SMC contraction and decreases blood pressure in spontaneously hypertensive rats (52) . Therefore, we assessed the activation of the Rho/ROCK pathway in the mesenteric arteries of profilin1 mice. Our results showed that overexpression of profilin1 in the medial layer of mesenteric arteries led to the activation of Rho protein as indicated by the significant increase in the Rho-GTPase activity (260 Ϯ 6.2%; P Ͻ 0.05) and the significant increase in the protein expression of ROCKII kinase in profilin1 mesenteric arteries (350 Ϯ 4.4%; P Ͻ 0.05) (Fig. 4, A and B) . eNOS expression and activation are decreased in profilin1 mesenteric arteries. A previous study showed that both active RhoA and ROCK not only downregulate eNOS gene expression but also inhibit eNOS phosphorylation (31) . To determine whether the activation of the Rho/ROCK pathway in profilin1 mesenteric arteries affects the regulation of eNOS expression and activation, Western blotting was performed in mesenteric lysates from profilin1 and control mice to determine the ex- pression and phosphorylation of eNOS. Our results showed decreased eNOS protein levels and decreased activation of eNOS in mesenteric arteries of profilin1 mice (39 Ϯ 5.4 and 35 Ϯ 4.5%, respectively; P Ͻ 0.05) (Fig. 5, A and B) .
MLC is activated in the profilin1 mesenteric arteries. The Rho-GTPase is implicated in MLC 20 phosphorylation, which results in contraction of smooth muscle (22) . The GTP-bound, active form of RhoA (GTP-RhoA) specifically interacts with the myosin-binding subunit (MBS) of myosin phosphatase, which regulates the extent of phosphorylation of MLC 20 . ROCKII, which is activated by GTP-RhoA, phosphorylates MBS and consequently inactivates myosin phosphatase, thus increasing MLC 20 phosphorylation (57). Therefore, we sought to assess the activation of MLC 20 in the mesenteric arteries of profilin1 mice and nontransgenic controls using Western blotting. Our results showed a significant increase in the activation of MLC 20 in profilin1 transgenic mice (372 Ϯ 5.52%; P Ͻ 0.05) compared with nontransgenic controls (Fig. 5C) .
Phenylephrine significantly increases the contraction on profilin1 mesenteric arteries. Phenylephrine is a vasoconstrictor with ␣ 1 -adrenergic receptor agonist activity. Therefore, in this experiment, we used phenylephrine to assess the change of the vasoreactivity toward ␣ 1 -agonist as a result of profilin1 overexpression in resistant arteries. The effect of phenylephrine on vasoreactivity of mesenteric arteries (n ϭ 8) from profilin1 mice was measured using wire-myograph. Our results showed a significant increase in the vasocontraction response of profilin1 mesenteric arteries (EC 50 ϭ 1.01 Ϯ 0.90 M) compared with nontransgenic controls (EC 50 ϭ 3.90 Ϯ 1.32 M). The mesenteric artery tissues were cumulatively and concentration-dependently contracted by phenylephrine (Fig. 6A) .
The relaxant response of profilin1 mesenteric arteries is decreased with ACh treatment. ACh is an endogenous mediator that stimulates muscarinic receptors in the resistance vessels causing vessel relaxation. In this experiment, we sought to assess whether the profilin1-induced stress fibers modulate changes in the vasoreactivity toward ACh. In addition, we sought also to assess the endothelial functionality and integrity as a result of vascular hypertrophy. The effect of ACh on vasoreactivity of mesenteric arteries (n ϭ 8) from profilin1 mice was measured using wire-myograph.
After the vascular tissues were constricted with phenylephrine (1-3 M), ACh was applied cumulatively (0.01-10.00 M). Our results showed a significant decrease in the vasorelaxant response of profilin1 mesenteric arteries compared with nontransgenic controls. The phenylephrine-constricted mesenteric artery tissues were concentration-dependently relaxed by ACh with an EC 50 of 316 Ϯ 6.31 nM in profilin1 transgenic mice and EC 50 of 100.00 Ϯ 7.25 nM in nontransgenic controls (Fig. 6B) .
The relaxant response of profilin1 mesenteric arteries is decreased with sodium nitrite treatment. Sodium nitrite can be converted into nitric oxide, the common smooth muscle relaxing factor that is synthesized by the endothelial eNOS gene. Because of the activation of the Rho/ROCK pathway and the decrease in eNOS expression and activation in profilin1 mesenteric arteries, we sought to determine the change in the vasoreactivity of the profilin1 mesenteric arteries toward sodium nitrite compared with control. The effect of sodium nitrite on vasoreactivity of mesenteric arteries (n ϭ 8) from profilin1 mice was measured using wire-myograph. After the vascular tissues were constricted with phenylephrine (1-3 M), sodium nitrite was applied. Our results showed a significant decrease in the vasorelaxant response of profilin1 mesenteric arteries compared with nontransgenic controls. The phenylephrine-constricted mesenteric artery tissues were cumulatively and concentration-dependently relaxed by sodium nitrite with an EC 50 of 764 Ϯ 4.23 M in profilin1 transgenic mice and 375 Ϯ 5.32 M in nontransgenic controls (Fig. 7A) . Sodium nitrite (75-2,000 M) alone had no effect on the basal tension of mouse mesenteric arteries.
ROCK inhibitor relaxes phenylephrine-contracted profilin1 mesenteric arteries.
A previous study showed that a specific inhibition of ROCK prevented agonist-induced SMC contraction and decreased blood pressure in spontaneously hypertensive rats (52) .
Another study reported that the ROCK inhibitor Y-27632 markedly reduced systemic blood pressure and decreased renal damage in animal models of kidney disease (54) .
Our report showed the activation of the Rho/ROCK pathway in the profilin1 mesenteric arteries. Therefore, we next investigated the effects of the ROCK inhibitor Y-27632 on phenylephrine-contracted profilin1 mesenteric arteries compared with control using wire-myograph (n ϭ 8). Our results showed relaxation of the phenylephrine-contracted profilin1 mesenteric arteries. However, the Y-27632 concentrations that were required to inhibit the contracted profilin1 mesenteric arteries were significantly higher than those concentrations used with controls because of the significantly higher level of ROCKII expression in the profilin1 mesenteric arteries. The EC 50 of Y-27632 in profilin1 mice was higher compared with nontransgenic controls (9.9 Ϯ 2.3 and 2.1 Ϯ 1.1 M, respectively; P Ͻ 0.05) (Fig. 7B) . ) and control (□) subjects. B: concentration-response curves to ACh in mesenteric arteries (n ϭ 8) of profilin1 ( ) and control (□) mice. Data are presented as means Ϯ SE. *A value of P Ͻ 0.05 was considered significant.
The relaxant response of profilin1 mesenteric arteries is decreased with cytochalasin D treatment. Cytochalasin D is an actin-depolarizing agent that was used in this experiment to confirm the role of F-actin in increasing the vasoconstriction of profilin1 mesenteric arteries in response to phenylephrine treatment. The effect of cytochalasin D on vasoreactivity of mesenteric arteries (n ϭ 8) from profilin1 mice was measured using wire-myograph. After the vascular tissues were constricted with phenylephrine (1-3 M), cytochalasin D was applied. Our results showed a significant decrease in the vasorelaxant response of profilin1 mesenteric arteries compared with nontransgenic controls. The phenylephrine-constricted mesenteric artery tissues were cumulatively and concentration-dependently relaxed by cytochalasin D with an EC 50 of 302 Ϯ 4.12 nM in profilin1 transgenic mice and 110 Ϯ 6.10 nM in nontransgenic controls (Fig. 7C) . Cytochalasin D (50 -800 nM) alone had no effect on the basal tension of mouse mesenteric arteries.
DISCUSSION
The goal of our study was to assess the functional changes of the resistance arteries toward vasoactive agents due to vascular hypertrophy caused by increased stress fiber formation in the medial layer of profilin1 resistance arteries. We have shown before that overexpression of profilin1 led to increased stress fiber formation and actin polymerization as was evident by increasing the F-to G-actin ratio in aortic SMC from profilin1 mice (32) . In the current report, we confirmed the overexpression of profilin1 protein in the mesenteric arteries of the profilin1 transgenic mice and showed clear signs of medial hypertrophy in cross sections of profilin1 mesenteric arteries stained with H&E.
It is well established that mechanical stretch or hypertension leads to remodeling of large and small arteries (11, 32, 48) . In our previous study, we demonstrated that increased expression of profilin1 in VSMCs resulted in alteration of the cytoskeleton dynamic, favoring increased actin polymerization that can lead to hypertrophy in large vessels and elevation in blood pressure in older profilin1 mice (32) . Vascular remodeling is believed to be an adaptive process in response to chronic changes in hemodynamic conditions during development and vascular pathologies (12, 15, 24, 51, 55) . Furthermore, increased actin polymerization and stress fiber formation generate mechanical force that may play a role in the modulation of cellular morphology and function (39) . It is likely that the extracellular matrix integrin-cytoskeleton axis plays an essential role in the mechanosensory apparatus that enables VSMCs to detect and respond to changes in mechanical stress. Integrins are heterodimeric cell-surface receptors that link the extracellular matrix and the intracellular cytoskeleton and function as mechanotransducers (2) . Our preliminary experiments show an increase in the expression of extracellular matrix-collagen 1 on profilin1 aortas (data not shown). In this report, our results showed significant increases in ␣ 1 -and ␤ 1 -integrins in the profilin1 mesenteric arteries compared with controls. Integrins may act not only as mediators of cell adhesion but they can also transduce biochemical signals across the cell membrane and activate intracellular signaling (i.e., Rho/ROCK, ERK1,2, and JNK pathways) (28, 32). Our results are in agreement with another report that showed that mechanical stretching signals are mainly transduced by cell adhesion molecules such as ␣ 1 ␤ 1 -integrins, which are known to bind collagen and are implicated in arterial stiffness (28) .
During cell stimulation by mechanical stretch, several signaling events are associated with the formation of focal adhesions, which consist of clustered integrins and accumulated cytoskeletal proteins (3, 38) . Proteins present at focal adhesions, in particular the 125-kDa cytoplasmic tyrosine kinase FAK, becomes tyrosine phosphorylated when cells are stimulated (5, 19, 23, 26, 27) . Rho, a small G protein, is also implicated in the regulation of the formation of stress fibers and focal adhesions, through phosphorylation of FAK (5, 8, 16, 20, 45) . Our preliminary results showed the activation of FAK and its downstream signaling of ␤PIX and Rac1 in the aortas of profilin1 mice (data not shown). Activation of this pathway leads to the activation of the MAP kinase cascade, which is a major pathway through which signals coming from growth factors and mechanical strain are transduced into the regulation of gene expression and protein synthesis (1, 13, 29, 59) .
We showed in this report the activation of JNKs and ERKs in mesenteric arteries of profilin1 mice, which represent key kinases in the hypertrophic signaling pathway (32) . Other studies found that mechanical stretch or hypertension can rapidly induce activation of JNK and ERK1/2 in vascular walls after balloon injury or angioplasty in animal models (18, 37) , suggesting that mechanical stretch is closely related to JNK and ERK1/2 activation. Activation of JNK and ERK signaling pathways leads to increased c-fos and c-jun gene expression and enhanced transcription factor AP-1 DNA binding activity, contributing to increased gene expression and protein synthesis (18) .
Furthermore, mechanical stretch/hypertension can also affect the small GTP-binding protein Rho pathway. Rho and ROCK play an important role in vascular remodeling and blood pressure regulation, particularly hypertension (46) . Our results showed inhibition in the expression and activation of eNOS in the profilin1 mesenteric arteries, which could contribute to hypertension in the older profilin1 mice. A previous study showed that both active RhoA and ROCK not only downregulate eNOS gene expression but also inhibit eNOS phosphorylation (31) . This study showed that the Rho/ROCK pathway negatively regulates eNOS activation through the inhibition of protein kinase B (Akt), whereas it downregulates eNOS expression independent of Akt (31).
Furthermore, activated Rho elevates MLC 20 phosphorylation by 1) directly phosphorylating MLC 20 and 2) phosphorylation and inhibition of the MBS of MLC 20 phosphatase (16, 36) . This increases myosin contractility and tension contributing to stress fibers. Our results showed a significant increase in Rho-GTPase activity and the expression of the ROCK in mesenteric arteries of profilin1 mice. In addition, there was a significant activation of MLC 20 in mesenteric arteries. The activation of the Rho/ROCK pathway and MLC 20 phosphorylation along with increased actin polymerization (32) significantly contributed to increased SMC contractility.
We next assessed the vasoreactivity of mesenteric arteries toward vasoactive agents to determine the functional modulations in resistance arteries due to the vascular hypertrophy in profilin1 mice. We used phenylephrine as a vasoconstrictor and ACh and sodium nitrite as vasorelaxants. Our results showed a significant increase in the contraction response of profilin1 mesenteric arteries toward phenylephrine and significant decreases in the relaxation response toward ACh and sodium nitrite compared with nontransgenic controls. The effect of the ROCK inhibitor Y-27632 significantly relaxes the phenylephrine-contracted profilin1 mesenteric arteries. The Y-27632 concentrations that were required to relax the contracted profilin1 mesenteric arteries were higher than those concentrations used with controls because of the significantly higher level of ROCKII expression in the profilin1 mesenteric arteries. Our results are in agreement with other reports that showed the Y-27632 inhibitor prevents agonist-induced SMC contraction and decreases blood pressure in spontaneously hypertensive rats (48 -52) . Additionally, Y-27632 inhibitor markedly reduced systemic blood pressure and decreases renal damage in animal models of kidney disease (54) .
We also assessed the effect of cytochalasin D on the contractile response of phenylephrine stimulation to show that profilin1-induced stress fiber formation (32) may play a role in increasing the vasoconstriction of profilin1 mesenteric arteries in response to phenylephrine treatment. Our results showed that cytochalasin D significantly relaxes the phenylephrinecontracted mesenteric arteries. However, cytochalasin D concentrations that were required to inhibit the contracted profilin1 mesenteric arteries were higher than those concentrations used with controls because of the high levels of stress fiber formation in VSMCs as we showed in the previous report (32) . Thus the inhibitory effect of cytochalasin D on mesenteric artery contractility induced by phenylephrine was decreased in profilin1 transgenic mice compared with nontransgenic controls. Although it needs to be confirmed, we suggest that the increased constriction of mesenteric arteries to phenylephrine could be because of the increased F-to G-actin ratio; however, cytochalasin D treatment reduced this ratio. Receptor-coupled activation of SMCs has been shown to result in increases in the proportion of F-actin and corresponding decreases in the amount of G-actin. Consequently, treatment of SMCs with either cytochalasin D or latrunculin B has been shown to reduce the receptor-coupled increases in the F-to G-actin ratio (8) .
Our current report showed that profilin1 plays a significant role in increased contractility and force development in the mesenteric arteries of profilin1 mice, not only by increasing actin polymerization (32) but also by activating MLC 20 . These synergic effects of profilin1 increased the force development of mesenteric arteries toward vasoactive agents. The study by Tang and Tan (50) was in agreement with our results; they showed that treatment of carotid smooth muscle strips with profilin1 antisense oligodeoxynucleotides inhibited the force generation in response to stimulation with norepinephrine or KCl than in profilin sense-treated strips. In addition, the increase in the F-to G-actin ratio during contractile stimulation was significantly inhibited in profilin-deficient smooth muscle strips. These results suggest that profilin1 is a necessary molecule of signaling cascades that regulates carotid smooth muscle contraction but that it does not modulate MLC 20 phosphorylation during contractile stimulation (50) .
In more recent experiments, we assessed the effect of normalizing blood pressure in profilin1 mice on the vascular hypertrophy using three antihypertensive drugs (atenolol, amlodipine, losartan) that were supplemented in the drinking water for 4 wk.
Our results showed that these treatments lowered blood pressure in profilin1 mice and reduced the degree of vascular hypertrophy, but did not completely abolish it (data not shown). These results suggested that profilin1-induced stress fiber formation that led to increased mechanical stress on profilin1 blood vessels is the primary trigger of vascular hypertrophy, since it is expressed during embryogenesis and after birth. This hypertrophy led to increased stiffening of blood vessels and resulted in elevation of blood pressure when the mice were six months old. Thus the synergistic effects between vascular hypertrophy and the elevation of blood pressure contributed to the functional changes in the profilin1 mesenteric arteries.
Our preliminary study showed that an increase in profilin1 expression in the aortic medial layers of older wild-type mice compared with young mice indicates that profilin1 increases by age (data not shown). Furthermore, other indirect evidence showed that profilin1 increased with age; a recent study using proteomic and genomic analyses of hippocampus from young and old rats showed a significant increase in profilin1 expression in aged rat hippocampus (56) . Another study investigating differential protein expression profiles in chronically stimulated T cell clones found that profilin1 was widely and highly expressed in cytoplasm (30) . The study concluded that differential expression of profilin1 in aging may contribute directly to immunosenescence via disrupting the intracellular signaling and intercellular communication (9, 58) . A study by Romeo et al. (42) in 2004, showed that profilin1 protein levels were increased in the aortas of diabetic rats and diabetic individuals as well as within atherosclerotic plaques. Additionally, attenuation of profilin1 levels protected against atherosclerosis and endothelial dysfunction upon high-fat feeding (43) .
The significance of this work is that, until now, it has not been completely understood how age-related changes in vasculature lead to hypertension in middle-age humans. This profilin1 model might serve as an accelerated model for vascular aging that leads to development of hypertension. This model allows us to study the temporal changes in vascular signaling that lead to structural and functional remodeling that predict a higher risk for developing arteriosclerosis, hypertension, stroke, and heart failure. Increased profilin1 in the vessels could be an index for arterial aging. This profilin1 model may be a very useful tool that could allow a better understanding of how changes in vessel wall structure contribute to arterial stiffening and hypertension. Finally, understanding the signaling pathways involved in vascular remodeling may be of help in the development of novel therapeutic strategies for the treatment of arterial stiffening and hypertension. In addition to conventional antihypertensive therapy, it may well be that the future of blood pressure treatment could also center on maintaining normal vascular function in this manner.
